Merck said its board authorized an additional $10 billion share repurchase authorization, which has no time limit for completion. The maker of medicines and vaccines has a market cap of $247.75 ...

The vaccines that will be used to protect livestock against foot and mouth disease from this week are safe, the national vaccine maker has said.At the same time, the Kenya Veterinary Vaccine ...

The Senate Finance Committee will meet on Jan. 29 to discuss the confirmation of RFK Jr., whose stances on vaccines and abortion have raised questions from Democrats and Republicans alike.

The global Veterinary Vaccines Market, valued at US$8.93 billion in 2023, is forecasted to grow at a robust CAGR of 6.1%, reaching US$9.39 billion ...

Veterinary Pharmaceutical Drug Market Expected To Achieve A Strong 5.07% CAGR, To Reach USD 40.3 Billion By 2032 The rising trend of pet ownership across various regions has significantly impacted the ...

The global veterinary biologics market is projected to grow from USD 13,140.6 million in 2024 to USD 24,224.3 million by 2034 ...

Merck & Co has begun a rolling filing in the US of its Ebola Zaire vaccine, known as V920, after the FDA said it could represent a breakthrough in treatment. Known as MSD outside the US ...

Merck also hopes to close the future gap from loss of Keytruda sales with its pipeline of antibody-drug conjugates, sales of its Gardasil vaccine in China and the possible introduction of an oral ...

In the veterinary world, this has been addressed with “vaccination guidelines” put out by various professional organizations. These guidelines suggest which vaccines to consider “core ...